National Cancer Institute's Ned Sharpless to be Acting FDA Head - Bloomberg

(Updated - March 12, 2019 12:33 PM EDT)

(Updated - March 12, 2019 12:29 PM EDT)

U.S. Secretary for Health and Human Services Alex Azar announced at a subcommittee hearing that Ned Sharpless, currently director of the National Cancer Institute, will become acting FDA commissioner in early April, according to a report from Bloomberg.

You May Also Be Interested In

• J&J myeloma drug combo shows survival gains in Phase 3 data
• Propanc releases preclinical PDAC data for PRP, eyes 2027 trial
• FDA grants fast track status to Quoin drug for peeling skin syndrome